Abstract
Obstructive sleep apnea (OSA) is a syndrome with repeated obstruction of the upper airway which results in cessation of airflow, with disturbance in saturation followed by arousals from sleep. Loud snoring and witnessed apnea are the cardinal symptoms of OSA, but these symptoms cannot be self-reported. OSA can be associated with impaired quality of life, depressive mood, and excessive daytime sleepiness.
Positive airway pressure (PAP) is the first-line option in treatment of obstructive sleep apnea. For effective outcomes, PAP treatment should be at least 4 h per night. Excessive daytime sleepiness, impaired quality of life, and depressive mood are expected to be healed with CPAP treatment in OSA.
Most of the researches reported that with an effective PAP compliance, daytime symptoms, quality of life, and depressive mood can be improved; however there also studies that addressed no positive effect of CPAP therapy on these clinical outcomes.
In this chapter the association of OSA with impaired quality of life, depression, and excessive daytime sleepiness will be evaluated; moreover, impact of CPAP treatment on these self-reported outcomes will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- APAP:
-
Auto-adjusting positive airway pressure
- AHI:
-
Apnea–hypopnea index
- BPAP:
-
Bi-level positive airway pressure
- CES-D:
-
Center for Epidemiologic Studies Depression Scale
- CPAP:
-
Continuous positive airway pressure
- EDS:
-
Excessive daytime sleepiness
- ESS:
-
Epworth Sleepiness Scale
- FOSQ:
-
Functional Outcomes of Sleep Questionnaire
- HADS:
-
Hospital Anxiety and Depression Scale
- HDRS:
-
Hamilton Depression Rating Scale
- ODI:
-
Oxygen desaturation index
- OSA:
-
Obstructive sleep apnea
- PAP:
-
Positive airway pressure
- PICO:
-
Patient, population or problem, intervention, comparison, and outcomes
- POMS:
-
Profile of Mood States
- QSQ:
-
Quebec Sleep Questionnaire
- RDI:
-
Respiratory disturbance index
- REI:
-
Respiratory event index
- SF-36:
-
Short Form of the Medical Outcomes Survey
- ZDS:
-
Zung Self-rating Depression Scale
References
Bradley TD, Phillipson EA. Pathogenesis and pathophysiology of the obstructive sleep apnea syndrome. Med Clin North Am. 1985;69:1169–85.
Thunstrom E, Manhem K, Yucel-Lindberg T, Rosengren A, Lindberg C, Peker Y. Neuroendocrine and inflammatory responses to losartan and continuous positive airway pressure in patients with hypertension and obstructive sleep apnea. A randomized controlled trial. Ann Am Thorac Soc. 2016;13:2002–11.
Lynch MK, Elliott LC, Avis KT, Schwebel DC, Goodin BR. Quality of life in youth with obstructive sleep apnea syndrome (osas) treated with continuous positive airway pressure (cpap) therapy. Behav Sleep Med. 2019;17:238–45.
Balcan B, Thunstrom E, Strollo PJ Jr, Peker Y. Determinants of depressive mood in coronary artery disease patients with obstructive sleep apnea and response to continuous positive airway pressure treatment in non-sleepy and sleepy phenotypes in the riccadsa cohort. J Sleep Res. 2019;28:e12818.
Brewster GS, Hirschman KB, Riegel BJ, Hanlon AL, Huang L, McPhillips MV, et al. Association of health related quality of life domains with daytime sleepiness among elderly recipients of long-term services and supports. Geriatr Nurs. 2019;40:417.
Batool-Anwar S, Goodwin JL, Kushida CA, Walsh JA, Simon RD, Nichols DA, et al. Impact of continuous positive airway pressure (cpap) on quality of life in patients with obstructive sleep apnea (osa). J Sleep Res. 2016;25:731–8.
Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an american academy of sleep medicine systematic review, meta-analysis, and grade assessment. J Clin Sleep Med. 2019;15:335–43.
Hoyos CM, Bartlett DJ, Phillips CL. Is obstructive sleep apnea a risk factor for depression in coronary artery disease? Ann Am Thorac Soc. 2019;16:49–50.
Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry. 2003;64:1195–200. quiz: 274–6.
Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the beck depression scale. Sleep Med. 2003;4:343–5.
Wahner-Roedler DL, Olson EJ, Narayanan S, Sood R, Hanson AC, Loehrer LL, et al. Gender-specific differences in a patient population with obstructive sleep apnea-hypopnea syndrome. Gend Med. 2007;4:329–38.
Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, et al. The effect of cpap in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe osa. Sleep. 2011;34:111–9.
Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, et al. Relationship between hours of cpap use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30:711–9.
McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S, Davies RJ, et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (predict): a 12-month, multicentre, randomised trial. Lancet Respir Med. 2014;2:804–12.
Campos-Rodriguez F, Queipo-Corona C, Carmona-Bernal C, Jurado-Gamez B, Cordero-Guevara J, Reyes-Nunez N, et al. Continuous positive airway pressure improves quality of life in women with obstructive sleep apnea. A randomized controlled trial. Am J Respir Crit Care Med. 2016;194:1286–94.
Foster SN, Hansen SL, Scalzitti NJ, Matsangas P, Moore BA, Mysliwiec V. Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy. Sleep Breath. 2019;22:589.
Lewis EF, Wang R, Punjabi N, Gottlieb DJ, Quan SF, Bhatt DL, et al. Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: a heart biomarker evaluation in apnea treatment (heartbeat) analysis. Am Heart J. 2017;189:59–67.
Zhao YY, Wang R, Gleason KJ, Lewis EF, Quan SF, Toth CM, et al. Effect of continuous positive airway pressure treatment on health-related quality of life and sleepiness in high cardiovascular risk individuals with sleep apnea: best apnea interventions for research (bestair) trial. Sleep. 2017;40(4)
Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med. 2001;134:1015–23.
Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165:773–80.
Phillips CL, Yee BJ, Marshall NS, Liu PY, Sullivan DR, Grunstein RR. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med. 2011;184:355–61.
Gupta MA, Simpson FC, Lyons DC. The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: a systematic review and meta-analysis. Sleep Med Rev. 2016;28:55–68.
El-Sherbini AM, Bediwy AS, El-Mitwalli A. Association between obstructive sleep apnea (osa) and depression and the effect of continuous positive airway pressure (cpap) treatment. Neuropsychiatr Dis Treat. 2011;7:715–21.
Haensel A, Norman D, Natarajan L, Bardwell WA, Ancoli-Israel S, Dimsdale JE. Effect of a 2 week cpap treatment on mood states in patients with obstructive sleep apnea: a double-blind trial. Sleep Breath. 2007;11:239–44.
Diamanti C, Manali E, Ginieri-Coccossis M, Vougas K, Cholidou K, Markozannes E, et al. Depression, physical activity, energy consumption, and quality of life in osa patients before and after cpap treatment. Sleep Breath. 2013;17:1159–68.
Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with cpap compared with conservative therapy. Am J Respir Crit Care Med. 1998;157:858–65.
Gagnadoux F, Le Vaillant M, Goupil F, Pigeanne T, Chollet S, Masson P, et al. Depressive symptoms before and after long-term cpap therapy in patients with sleep apnea. Chest. 2014;145:1025–31.
Borak J, Cieslicki J, Szelenberger W, Wilczak-Szadkowska H, Koziej M, Zielinski J. Psychopathological characteristics of the consequences of obstructive sleep apnea prior to and tree months after cpap. Psychiatr Pol. 1994;28:33–44.
Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:656–64.
Balcan B, Thunstrom E, Strollo PJ Jr, Peker Y. Continuous positive airway pressure treatment and depression in adults with coronary artery disease and nonsleepy obstructive sleep apnea. A secondary analysis of the riccadsa trial. Ann Am Thorac Soc. 2019;16:62–70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Balcan, B. (2020). Impact of Positive Airway Pressure on Quality of Life, Excessive Daytime Sleepiness and Depressive Mood in Patients with Obstructive Sleep Apnea. In: Esquinas, A.M., et al. Noninvasive Ventilation in Sleep Medicine and Pulmonary Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-42998-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-42998-0_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42997-3
Online ISBN: 978-3-030-42998-0
eBook Packages: MedicineMedicine (R0)